Journal
BIOLOGICAL PSYCHIATRY
Volume 67, Issue 10, Pages 926-932Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.biopsych.2009.10.025
Keywords
Antipsychotic drugs; hippocampus; human; memory; schizophrenia
Categories
Funding
- National Alliance for Research on Schizophrenia and Depression, National Institute of Mental Health [5R01-MH080309, 1 R34 MH075863, SMRI 05-RC-001, 5F32MH072135]
Ask authors/readers for more resources
Background: Schizophrenia involves alterations in hippocampal function. The implications of these alterations for memory function in the illness remain poorly understood. Furthermore, it remains unknown how memory is impacted by drug treatments for schizophrenia. The goal of this study was to delineate specific memory processes that are disrupted in schizophrenia and explore how they are affected by medication. We specifically focus on memory generalization the ability to flexibly generalize memories in novel situations. Methods: Individuals with schizophrenia (n = 56) and healthy control subjects (n = 20) were tested on a computerized memory generalization paradigm. Participants first engaged in trial-by-error associative learning. They were then asked to generalize what they learned by responding to novel stimulus combinations. Individuals with schizophrenia were tested on or off antipsychotic medication, using a between-subject design in order to eliminate concerns about learning-set effects. Results: Individuals with schizophrenia were selectively impaired in their ability to generalize knowledge, despite having intact learning and memory accuracy. This impairment was found only in individuals tested off medication. Individuals tested on medication generalized almost as well as healthy control subjects. This between-group difference was selective to memory generalization. Conclusions: These findings suggest that individuals with schizophrenia have a selective alteration in the ability to flexibly generalize past experience toward novel learning environments. This alteration is unaccompanied by global memory impairments. Additionally, the results indicate a robust generalization difference on the basis of medication status. These results suggest that hippocampal abnormalities in schizophrenia might be alleviated with antipsychotic medication, with important implications for understanding adaptive memory-guided behavior.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available